Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Access this Article
Search this Article
Author(s)
Journal
-
- Cancer Science
-
Cancer Science 108(10), 1947-1952, 2017-10
John Wiley & Sons